CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis.

• Main Authors: Seth G Thacker (Author), Ian L McWilliams (Author), Beatrice Bonnet (Author), Lydia Halie (Author), Serge Beaucage (Author), Swaksha Rachuri (Author), Ranadhir Dey (Author), Robert Duncan (Author), Farrokh Modabber (Author), Stephen Robinson (Author), Graeme Bilbe (Author), Byron Arana (Author), Daniela Verthelyi (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2020-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cutaneous leishmaniasis (CL) affects the lives of 0.7-1 million people every year causing lesions that take months to heal. These lesions can result in disfiguring scars with psychological, social and economic consequences. Antimonials are the first line of therapy for CL, however the treatment is l...